medicalcare | Media Room | PressRelease.com

Tagged medicalcare

A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity

Press Release Jun 15, 2022

A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris. Read More

Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical

Press Release Oct 14, 2021

Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

First
Prev

1

Next
Last